Drug Research
University of East Anglia researchers make a breakthrough for next gen cancer treatment
University of East Anglia researchers make breakthrough for ‘next gen’ cancer treatment. These new treatments would be highly targeted and more effective than current state-of-the-art...
Drug Research
New BioAccelerator Expands Biomanufacturing Capacity for Canada
The Governments of Canada and Prince Edward Island (PEI) will invest $50 million in the BioAccelerator, the largest single investment in economic development infrastructure in...
Drug Research
BioMed X Launches New T Cell Immunology Discovery Platform
BioMed X unveiled its new immunology discovery platform designed to allow for the accurate and fast identification of target antigens of human T cell receptors...
Drug Research
Lonza Completes Expansion of Conjugation Facility in Visp
Lonza, a partner to the pharmaceutical, biotech and nutraceutical markets, has completed a planned expansion of its bioconjugation facility in Visp, Switzerland.
The expansion includes two...
IT & Data Management
Australia Creates First In The World Biotech ESG Guidance
A group of committed AusBiotech leaders has joined forces to create an Australian biotech first: a sector-specific environmental, social, and governance (ESG) tool in order...
Clinical Trials
Long Term Survival In Lung Cancer Can Be A Possibility
Final assessments of a Phase II trial for resectable non-small cell lung cancer found that 60% of patients who had gone on to receive the...
News
Three Novel Ways Tested By CMS To Lower The Cost of Drugs
It has come to light that the federal health agencies have gone on to select three new models so as to lower the prices of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.